In this study we describe some biological effects of IL-34, a newly discovered cytokine. We show that 11-34 stimulates monocyte cell viability and directly modulates the number and function of monocytes and regulates myeloid cell growth and differentiation. Moreover, since IL-34 in mice is involved in osteoporosis, an antagonist of this cytokine could be beneficial for the treatment of this disease.
. Some ligands have highly specific functions because their receptors are expressed in a limited number of tissues, whereas other ligands act on a broad spectrum of tissues. The amino acid sequence of human lL-34 shares a sequence identity of 99.6%, 72%, and 71% with that of the chimpanzee, rat, and mouse, respectively. lL-34 mRNA is expressed in various tissues, including heart, brain, lung, liver, kidney, spleen, thymus, testes, ovary, small intestine, prostate, and colon, and it is most abundant in the spleen. Consistent with its role in regulating myeloid cell growth and differentiation, lL-34 protein is also detectable by immuno-histochemistry in the sinusoidal endothelium in the red pulp of the spleen. Purified lL-34 protein increases the number of monocytes and its activity is detectable in an assay measuring DNA replication. lL-34 protein specifically bind to CDI4+ monocytes in peripheral blood mononuclear cells (PBMCs), but do not bind CD3+ T cells or CD56+ NK cells. The lL-34 receptor is called CSF-I R and the inhibitory activity of this receptor seems specific. The effect of lL-34 on monocyte viability is blocked by antibodies to lL-34 but not by an antibody toCSF-I, suggesting its specific effect. Moreover, lL-34 is a new ligand for a specific receptor CSF-I. lL-34-induced phosphorylation of ERKI/2 is inhibitedby a CSF-I R-specific inhibitor. In human bone marrow cell cultures, lL-34 promotes the formation of the colony-forming unit-macrophage (CFU-M), similar to those of colonies promoted by CSF-I (39-42). These two proteins, CSF-I and CSF-I R resultfundamental for monocyte formation and differentiation. It has been found that mice defective inCSF-I R have a more severe osteopetrosis, therefore, IL-34 is most likely involved in the metabolism of calcium.
In addition, it has been recently found that Equine Infectious Anemia Virus (ElAV) a retrovirus which causes a clinical disease related to the host immune response (and its S2 protein) affect the generation of cytokine and chemokine in macrophages, and S2 specifically induces the expression of IL-34 and optimizes the host cell environment to promote viral dissemination and replication. 
